Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
Document › Details

Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna.

Organisations Organisation Themis Bioscience N.V.
  Group Themis Bioscience (Group)
  Organisation 2 Euronext Amsterdam N.V.
  Group Euronext (Group)
Products Product Measles Vector (MV) technology platform
  Product 2 investment banking
Index term Index term Themis Bioscience–SEVERAL: investment, 201810– IPO €35m to €55.3m on Euronext Amsterdam POSTPONED 11/18
Persons Person Tauber, Erich (Themis Bioscience GmbH 201505 CEO)
  Person 2 Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke)
     


   
Record changed: 2018-11-12

Advertisement

Picture [iito] – Putting Information into Context 600x60px

More documents for Themis Bioscience (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px




» top